enVVeno Medical Participates in the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference
-
India thrash Zimbabwe in T20 World Cup, S.Africa into semi-finals
-
Danish PM calls March 24 election amid US, Russia tensions
-
Hillary Clinton calls for Trump to testify as she faces US House Epstein panel
-
Uruguay becomes first country to ratify EU-South America trade deal
-
Stocks diverge as investors digest Nvidia earnings
-
Tudor says turning round Tottenham his hardest job
-
EU says member states can use bloc's funds for 'safe' abortion access
-
More rain lashes southeast Brazil as death toll hits 54
-
Carney on route to Asia to promote Canada trade as US ties falter
-
Abhishek, Pandya fire India to 256-4 against Zimbabwe
-
Irish wing Lowe ruled out of rest of Six Nations
-
Cuba vows to counter 'terrorist' attacks after clashing with US-based boat
-
Swastikas tagged at former Nazi transit camp near Paris
-
Calls for heads to roll after feeble Sri Lanka T20 World Cup exit
-
Stocks mixed as investors digest Nvidia earnings
-
Noosha Aubel: Scandal in Potsdam over severely disabled child
-
Chaos as jihadist relatives left Syrian camp, witnesses say
-
Mother of Greek train tragedy victim takes on politicians in bid for 'justice'
-
No proven link between Duterte speeches and drug deaths, defence tells ICC
-
Athens court convicts four over Greece spyware saga
-
Iranian in possible France prisoner swap jailed for a year
-
US, Ukraine hold talks in Geneva as Russia says 'no deadlines' to end war
-
English giants dominate line-up for Champions League last-16 draw
-
Iran, US hold talks in push to avert war
-
South Africa thrash West Indies in T20 World Cup statement win
-
ECB books third straight annual loss
-
Injury forces Marquez to adapt for MotoGP opener
-
Booming markets propel Hong Kong exchange's profits to record high
-
West Indies recover from 83-7 to post to 176-8 against South Africa
-
Filmmakers defend Berlin festival chief in Gaza row
-
Hong Kong mogul Jimmy Lai wins appeal in fraud case
-
Iranian in possible prisoner exchange faces 'terrorism' verdict in France
-
'Street-smart' New Zealand can topple England to make T20 semis: coach
-
Iran-US talks begin in push to avert war
-
Merz says Germany, China must overcome trade gaps 'together'
-
Automaker Stellantis posts massive loss, pivots from EV
-
US, Ukraine to meet in Geneva after overnight Russian strikes
-
Snake-like robot unveiled for Fukushima debris removal
-
'Public lynching': Senegal cracks down on LGBTQ+ community
-
Hong Kong sentences father of wanted activist to 8 months in jail
-
The woman fighting to reclaim her face from Albania's 'AI minister'
-
Bulgaria ski station becomes refuge for digital nomads
-
Thai runner-up party seeks criminal case against election officials
-
North Korea's Kim shuns South but could 'get along' with US
-
Spurs win 10th straight, Pistons silence Thunder in battle of NBA's best
-
Germany's Merz visits China AI hub hoping for business deals
-
Post-uprising polls won't shake Nepal's delicate India-China balance
-
S.Korea's Park Chan-wook to head Cannes festival jury
-
Australian ex-PM says 'more important than ever' to ditch UK monarchy
-
Dressed for succession? Kim Jong Un, daughter fuel speculation with matching coats
enVVeno Medical Participates in the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference
- Video webcast now available on-demand
IRVINE, CA / ACCESS Newswire / July 22, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of deep venous disease, today announced that Rob Berman, CEO of enVVeno, participated in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference.
As part of the segment, Mr. Berman dove deeper into his dedication to the Company, how he got to where he is today and provided insight into why he is so passionate about the Company's products in development.
The on-demand video webcast is now available on virtualinvestorco.com as well as the Events page of the enVVeno website, envveno.com.
About enVVeno Medical Corporation
enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device Company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of deep venous disease. The Company's lead product, the VenoValve®, is a first-in-class surgical replacement venous valve being developed for the treatment of deep venous Chronic Venous Insuffihttps://virtualinvestorco.com/summer-spotlight/cy (CVI). The Company is also developing a non-surgical, transcatheter based replacement venous valve for the treatment of deep venous CVI called enVVe®. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the leg, and back to the heart and lungs. The VenoValve is currently being evaluated in the VenoValve U.S. pivotal study and the Company is currently performing the final testing necessary to seek approval for the pivotal trial for enVVe.
INVESTOR CONTACT:
Jenene Thomas, JTC Team, LLC
[email protected]
(908) 824-0775
MEDIA CONTACT:
Glenn Silver, FINN Partners
[email protected]
(973) 818-8198
SOURCE: enVVeno Medical Corporation
View the original press release on ACCESS Newswire
M.Thompson--AMWN
